About this trial
Despite the benefit of formocresol, there are toxic effects allergic reactions and local soft and hard tissue necrosis have been reported when such formaldehyde compounds were used clinically, however, the adverse effect of the clinically used of this compound are not widely reported. It has been stated that it has a side effect on the permanent successor although it results as a successful technique for the treatment of the primary teeth
Eligibility criteria
This trial accepts healthy volunteersQualifiers
4 -9 years old
Primary molars with no spontaneous or provoked pain
Primary molars with at least two-thirds of the root length were still present.
Primary molars with no sign of internal or other kinds of root or bone resorption.
Disqualifiers
Patients with systemic diseases (congenital or rheumatic heart disease, hepatitis, nephritis, tumor, cyclic neutropenia, leukemia, and children on long-term corticosteroid therapy).
Un-cooperative patients.
Un-restorable primary molars (Grossly broken-down primary molars that have decay extending way under the gingiva and tooth with root caries).
Trial design
Parallel
Treatments tested in this trial
A cotton pellet moistened with full-strength FC
DrugA cotton pellet moistened with full-strength FC will be placed for 5 minutes on the amputated pulp, after reaching hemostasis. The pulp stumps will be then covered by IRM (Intermediate Restorative Material).
Neo-Putty
DrugFollowing removal of the coronal pulp with a round bur and hemostasis, the pulp stumps in the study group will be covered with Neo-Putty ® according to the manufacturer's instructions. Neo-Putty will be placed in the prepared cavity, and then covered with a reinforced Zinc Oxide-Eugenol (IRM, Bayer-Leverkussen, Germany).
Treatment groups
Trial outcomes
Primary outcomes
Clinical success
• Success clinically and radiographically will assess by the number of participants with symptoms-free and no peri-radicular pathology
Sponsors and contacts
Click on the lead sponsor to view all of their trials.